Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles

Molecular Imaging

Volumn 10, Issue 1, 2011, Pages 56-68

  Tasciotti, Ennio ^a,b,c,d,e   Godin, Biana ^a,b,c,d,e   Martinez, Jonathan O ^a,b,c,d,e   Chiappini, Ciro ^a,b,c,d,e   Bhavane, Rohan ^a,b,c,d,e   Liu, Xuewu ^a,b,c,d,e   Ferrari, Mauro ^a,b,c,d,e  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c The University of Texas at Austin   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; DELIVERY SYSTEMS; ELEMENTAL ANALYSIS; EN-ROUTE; IN-VIVO; INTRAVENOUS INJECTIONS; MICRO-PARTICLES; NANO-POROUS SILICON; NEAR-INFRARED DYES; NEAR-INFRARED IMAGING; OPTICAL IMAGING SYSTEM; POROUS STRUCTURES; TARGET DELIVERY;

ANIMALS; ATOMIC SPECTROSCOPY; ELECTROMAGNETIC INDUCTION; ELECTRON SPECTROSCOPY; IMAGING SYSTEMS; INDUCTIVELY COUPLED PLASMA; NANOPARTICLES; THERMOGRAPHY (IMAGING);

INFRARED DEVICES;

NANOPARTICLE; SILICON;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; FLUOROMETRY; INFRARED SPECTROSCOPY; METHODOLOGY; MOUSE; NANOTECHNOLOGY; POROSITY;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; FLUOROMETRY; MICE; NANOPARTICLES; NANOTECHNOLOGY; POROSITY; SILICON; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 79951937727     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00011     Document Type: Article

References (50)

1. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001;19:316-7, doi:10.1038/86684.
2. Gobin AM, Lee MH, Halas NJ, et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 2007;7:1929-34, doi:10.1021/nl070610y. (Pubitemid 47197569)
3. Chen X, Conti PS, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res 2004;64:8009-14, doi:10.1158/0008-5472.CAN-04-1956. (Pubitemid 39446936)
4. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307:538-44, doi:10.1126/science. 1104274. (Pubitemid 40165671)
5. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2003;4:11-8, doi:10.1021/ nl0347334.
6. Li X, Coffer JL, Chen Y, et al. Transition metal complex-doped hydroxyapatite layers on porous silicon. J Am Chem Soc 1998;120: 11706-9, doi:10.1021/ja9823666. (Pubitemid 28543581)
7. Salonen J, Laitinen L, Kaukonen AM, et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J Control Release 2005;108:362-74, doi:10.1016/ j.jconrel.2005.08.017. (Pubitemid 41608668)
8. Anglin EJ, Cheng L, Freeman WR, Sailor MJ. Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev 2008;60: 1266-77, doi:10.1016/j.addr.2008.03.017.
9. Wu EC, Park JH, Park J, et al. Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles. ACS Nano 2008;2:2401-9, doi:10.1021/nn800592q.
10. Prestidge CA, Barnes TJ, Mierczynska-Vasilev A, et al. Loading and release of a model protein from porous silicon powders. Phys Status Solidi A 2007;204:3361-6, doi:10.1002/pssa.200723112. (Pubitemid 47608798)
11. Serda RE, Mack A, Pulikkathara M, et al. Cellular association and assembly of a multistage delivery system. Small 2010;6:1329-40, doi:10.1002/smll.201000126.
12. Tasciotti E, Liu X, Bhavane R, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008;3:151-7, doi:10.1038/nnano. 2008.34. (Pubitemid 351355132)
13. Bowditch AP, Waters K, Gale H, et al. In-vivo assessment of tissue compatibility and calcification of bulk and porous silicon. Mat Res Soc Symp Proc 1999;536:149-54.
14. Park J-H, Gu L, von Maltzahn G, et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 2009;8:331-6, doi:10.1038/nmat2398.
15. Low SP, Voelcker NH, Canham LT, Williams KA. The biocompatibility of porous silicon in tissues of the eye. Biomaterials 2009;30: 2873-80, doi:10.1016/j.biomaterials.2009.02.008.
16. Cheng L, Anglin E, Cunin F, et al. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drugdelivery vehicle. Br J Ophthalmol 2008;92:705-11, doi:10.1136/ bjo.2007.133587. (Pubitemid 351684186)
17. Canham LT. Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater 1995;7:1033-7, doi:10.1002/ adma.19950071215.
18. Godin B, Gu J, Serda RE, et al. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J Biomed Mater Res A 2010;94A:1236-43.
19. Anderson SHC, Elliott H, Wallis DJ, et al. Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions. Phys Status Solidi A 2003;197:331-5, doi:10.1002/pssa.200306519.
20. Bisi O, Ossicini S, Pavesi L. Porous silicon: a quantum sponge structure for silicon based optoelectronics. Surf Sci Rep 2000;38:1-126, doi:10.1016/S0167-5729(99)00012-6.
21. Cunin F, Schmedake TA, Link JR, et al. Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater 2002;1: 39-41, doi:10.1038/nmat702.
22. Canham LT. Silicon quantum wire array fabrication by electrochemical and chemical dissolution of wafers. Appl Phys Lett 1990; 57:1046-8, doi:10.1063/1.103561.
23. Herino R. Pore size distribution in porous silicon. In: Canham LT, editor. The properties of porous silicon. London: Inspec/IEE; 1997. p. 89-96.
24. Sakamoto J, Annapragada A, Decuzzi P, Ferrari M. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 2007;4:359-69, doi:10.1517/17425247.4.4.359. (Pubitemid 47249137)
25. Riehemann K, Schneider SW, Luger TA, et al. Nanomedicine- challenge and perspectives. Angew Chem Int Ed 2009;48:872-97, doi:10.1002/anie.200802585.
26. Tanaka T, Mangala LS, Vivas-Mejia PE, et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010;70:3687-96, doi:10.1158/0008-5472.CAN-09-3931.
27. Chiappini C, Tasciotti E, Fakhoury JR, et al. Tailored porous silicon microparticles: fabrication and properties. Chemphyschem 2010;11:1029-35.
28. Ferrati S, Mack A, Chiappini C, et al. Intracellular trafficking of silicon particles and logic-embedded vectors. Nanoscale 2010;2: 1512-20, doi:10.1039/c0nr00227e.
29. Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 2010;141:320-7, doi:10.1016/j.jconrel.2009.10.014.
30. Xia B, Xiao S-J, Guo D-J, et al. Biofunctionalisation of porous silicon (PS) surfaces by using homobifunctional cross-linkers. J Mater Chem 2006;16:570-8, doi:10.1039/b511175g. (Pubitemid 43324433)
31. Khullar O, Frangioni JV, Grinstaff M, Colson YL. Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. Semin Thorac Cardiovasc Surg 2009;21:309-15, doi:10.1053/ j.semtcvs.2009.11.009.
32. Perini R, Choe R, Yodh AG, et al. Non-invasive assessment of tumor neovasculature: techniques and clinical applications. Cancer Metastasis Rev 2008;27:615-30, doi:10.1007/s10555-008-9147-6.
33. Wolf M, Ferrari M, Quaresima V. Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J Biomed Opt 2007;12:062104, doi:10.1117/1.2804899.
34. Mayer-Kuckuk P, Boskey AL. Molecular imaging promotes progress in orthopedic research. Bone 2006;39:965-77, doi:10.1016/ j.bone.2006.05.009. (Pubitemid 44528381)
35. Sanchez EQ, Chinnakotla S, Khan T, et al. Intraoperative imaging of pancreas transplant allografts using indocyanine green with laser fluorescence. Proc Bayl Univ Med Cent 2008;21:258-60.
36. Reuthebuch O, Haussler A, Genoni M, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest 2004;125:418-24, doi:10.1378/chest.125.2.418. (Pubitemid 38223617)
37. Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 2008;195: 850-3, doi:10.1016/j.amjsurg.2007.02.032. (Pubitemid 351749448)
38. Sampath L, Wang W, Sevick-Muraca EM. Near infrared fluorescent optical imaging for nodal staging. J Biomed Opt 2008;13:041312, doi:10.1117/1.2953498.
39. Salonen J, Kaukonen AM, Hirvonen J, Lehto VP. Mesoporous silicon in drug delivery applications. J Pharm Sci 2008;97:632-53, doi:10.1002/jps.20999. (Pubitemid 351293873)
40. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol 1992;62 Suppl 1:S3-10, doi:10.1016/0090-1229(92)90035-M.
41. Jugdaohsingh R, Anderson SH, Tucker KL, et al. Dietary silicon intake and absorption. Am J Clin Nutr 2002;75:887-93. (Pubitemid 34449679)
42. Carlisle EM. Silicon: a possible factor in bone calcification. Science 1970;167:279-80, doi:10.1126/science.167.3916.279.
43. Serda RE, Gu J, Burks JK, et al. Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A 2009;75:752-60.
44. Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A 2006;103:4930-4, doi:10. 1073/pnas.0600997103.
45. Evora C, Soriano I, Rogers RA, et al. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. J Control Release 1998;51:143-52, doi:10.1016/S0168-3659(97)00149-1. (Pubitemid 28252865)
46. Kenneth Ward W. A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol 2008;2: 768-77.
47. Serda RE, Ferrati S, Godin B, et al. Mitotic partitioning of silicon microparticles. Nanoscale 2009;1:250-9, doi:10.1039/b9nr 00138g.
48. Beletsi A, Panagi Z, Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. Int J Pharm 2005;298:233-41, doi:10.1016/j.ijpharm. 2005.03.024. (Pubitemid 40828344)
49. Bimbo LM, Sarparanta M, Santos HIA, et al. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010;4:3023-32, doi:10.1021/ nn901657w.
50. Ananta JS, Godin B, Sethi R, et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol 2010;5:815-21, doi:10.1038/ nnano.2010.203.